'Is insulin right for me?': Feasibility of a pilot randomised controlled trial and acceptability of a web-based intervention to reduce psychological barriers to insulin therapy among adults with type 2 diabetes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

'Is insulin right for me?' : Feasibility of a pilot randomised controlled trial and acceptability of a web-based intervention to reduce psychological barriers to insulin therapy among adults with type 2 diabetes. / Holmes-Truscott, Elizabeth; Holloway, Edith E.; Husin, Hanafi M.; Furler, John; Hagger, Virginia; Skinner, Timothy C.; Speight, Jane.

I: Diabetic Medicine, Bind 39, e14759, 2022.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Holmes-Truscott, E, Holloway, EE, Husin, HM, Furler, J, Hagger, V, Skinner, TC & Speight, J 2022, ''Is insulin right for me?': Feasibility of a pilot randomised controlled trial and acceptability of a web-based intervention to reduce psychological barriers to insulin therapy among adults with type 2 diabetes', Diabetic Medicine, bind 39, e14759. https://doi.org/10.1111/dme.14759

APA

Holmes-Truscott, E., Holloway, E. E., Husin, H. M., Furler, J., Hagger, V., Skinner, T. C., & Speight, J. (2022). 'Is insulin right for me?': Feasibility of a pilot randomised controlled trial and acceptability of a web-based intervention to reduce psychological barriers to insulin therapy among adults with type 2 diabetes. Diabetic Medicine, 39, [e14759]. https://doi.org/10.1111/dme.14759

Vancouver

Holmes-Truscott E, Holloway EE, Husin HM, Furler J, Hagger V, Skinner TC o.a. 'Is insulin right for me?': Feasibility of a pilot randomised controlled trial and acceptability of a web-based intervention to reduce psychological barriers to insulin therapy among adults with type 2 diabetes. Diabetic Medicine. 2022;39. e14759. https://doi.org/10.1111/dme.14759

Author

Holmes-Truscott, Elizabeth ; Holloway, Edith E. ; Husin, Hanafi M. ; Furler, John ; Hagger, Virginia ; Skinner, Timothy C. ; Speight, Jane. / 'Is insulin right for me?' : Feasibility of a pilot randomised controlled trial and acceptability of a web-based intervention to reduce psychological barriers to insulin therapy among adults with type 2 diabetes. I: Diabetic Medicine. 2022 ; Bind 39.

Bibtex

@article{7daa7ecc428241b5a581f0647657fdf5,
title = "'Is insulin right for me?': Feasibility of a pilot randomised controlled trial and acceptability of a web-based intervention to reduce psychological barriers to insulin therapy among adults with type 2 diabetes",
abstract = "AimsAcceptable and accessible interventions are needed to address {\textquoteleft}psychological insulin resistance{\textquoteright}, which is a common barrier to insulin uptake among adults with type 2 diabetes (T2D). Our aim was to test the feasibility of a randomised controlled trial (RCT) study design and acceptability of a theoretically grounded, psycho-educational, web-based resource to reduce negative insulin appraisals among adults with T2D.MethodsA double-blinded, parallel group, two-arm pilot RCT (1:1), comparing intervention with active control (existing online information about insulin). Eligible participants were Australian adults with T2D, taking oral diabetes medications. Exclusion criteria: prior use of injectable medicines; being {\textquoteleft}very willing{\textquoteright} to commence insulin. Primary outcomes: study feasibility (recruitment ease, protocol fulfilment, attrition, data completeness); secondary outcomes: intervention acceptability (intervention engagement, user feedback) and likely efficacy (negative Insulin Treatment Appraisal Scale [ITAS] scores at follow-up). Online surveys completed at baseline and 2 weeks.ResultsDuring 4-week recruitment, 76 people expressed interest: 51 eligible and 35 enrolled (intervention = 17, control = 18; median[interquartile range] age = 62[53, 69] years; 17 women). Protocol fulfilment achieved by 26 (74%) participants (n = 13 per arm), with low participant attrition (n = 6, 17%). Intervention acceptability was high (>80% endorsement, except format preference = 60%). ITAS negative scores differed between-groups at follow-up (M diff = −6.5, 95% confidence interval: −10.7 to −2.4), favouring the intervention.ConclusionsThis novel web-based resource (“Is insulin right for me?”) is acceptable and associated with a likely reduction in negative insulin appraisals, relative to existing resources. This pilot shows the study design is feasible and supports conduct of a fully powered RCT.",
keywords = "attitudes, intervention, psychological insulin resistance, randomised control trial, type 2 diabetes",
author = "Elizabeth Holmes-Truscott and Holloway, {Edith E.} and Husin, {Hanafi M.} and John Furler and Virginia Hagger and Skinner, {Timothy C.} and Jane Speight",
year = "2022",
doi = "10.1111/dme.14759",
language = "English",
volume = "39",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",

}

RIS

TY - JOUR

T1 - 'Is insulin right for me?'

T2 - Feasibility of a pilot randomised controlled trial and acceptability of a web-based intervention to reduce psychological barriers to insulin therapy among adults with type 2 diabetes

AU - Holmes-Truscott, Elizabeth

AU - Holloway, Edith E.

AU - Husin, Hanafi M.

AU - Furler, John

AU - Hagger, Virginia

AU - Skinner, Timothy C.

AU - Speight, Jane

PY - 2022

Y1 - 2022

N2 - AimsAcceptable and accessible interventions are needed to address ‘psychological insulin resistance’, which is a common barrier to insulin uptake among adults with type 2 diabetes (T2D). Our aim was to test the feasibility of a randomised controlled trial (RCT) study design and acceptability of a theoretically grounded, psycho-educational, web-based resource to reduce negative insulin appraisals among adults with T2D.MethodsA double-blinded, parallel group, two-arm pilot RCT (1:1), comparing intervention with active control (existing online information about insulin). Eligible participants were Australian adults with T2D, taking oral diabetes medications. Exclusion criteria: prior use of injectable medicines; being ‘very willing’ to commence insulin. Primary outcomes: study feasibility (recruitment ease, protocol fulfilment, attrition, data completeness); secondary outcomes: intervention acceptability (intervention engagement, user feedback) and likely efficacy (negative Insulin Treatment Appraisal Scale [ITAS] scores at follow-up). Online surveys completed at baseline and 2 weeks.ResultsDuring 4-week recruitment, 76 people expressed interest: 51 eligible and 35 enrolled (intervention = 17, control = 18; median[interquartile range] age = 62[53, 69] years; 17 women). Protocol fulfilment achieved by 26 (74%) participants (n = 13 per arm), with low participant attrition (n = 6, 17%). Intervention acceptability was high (>80% endorsement, except format preference = 60%). ITAS negative scores differed between-groups at follow-up (M diff = −6.5, 95% confidence interval: −10.7 to −2.4), favouring the intervention.ConclusionsThis novel web-based resource (“Is insulin right for me?”) is acceptable and associated with a likely reduction in negative insulin appraisals, relative to existing resources. This pilot shows the study design is feasible and supports conduct of a fully powered RCT.

AB - AimsAcceptable and accessible interventions are needed to address ‘psychological insulin resistance’, which is a common barrier to insulin uptake among adults with type 2 diabetes (T2D). Our aim was to test the feasibility of a randomised controlled trial (RCT) study design and acceptability of a theoretically grounded, psycho-educational, web-based resource to reduce negative insulin appraisals among adults with T2D.MethodsA double-blinded, parallel group, two-arm pilot RCT (1:1), comparing intervention with active control (existing online information about insulin). Eligible participants were Australian adults with T2D, taking oral diabetes medications. Exclusion criteria: prior use of injectable medicines; being ‘very willing’ to commence insulin. Primary outcomes: study feasibility (recruitment ease, protocol fulfilment, attrition, data completeness); secondary outcomes: intervention acceptability (intervention engagement, user feedback) and likely efficacy (negative Insulin Treatment Appraisal Scale [ITAS] scores at follow-up). Online surveys completed at baseline and 2 weeks.ResultsDuring 4-week recruitment, 76 people expressed interest: 51 eligible and 35 enrolled (intervention = 17, control = 18; median[interquartile range] age = 62[53, 69] years; 17 women). Protocol fulfilment achieved by 26 (74%) participants (n = 13 per arm), with low participant attrition (n = 6, 17%). Intervention acceptability was high (>80% endorsement, except format preference = 60%). ITAS negative scores differed between-groups at follow-up (M diff = −6.5, 95% confidence interval: −10.7 to −2.4), favouring the intervention.ConclusionsThis novel web-based resource (“Is insulin right for me?”) is acceptable and associated with a likely reduction in negative insulin appraisals, relative to existing resources. This pilot shows the study design is feasible and supports conduct of a fully powered RCT.

KW - attitudes

KW - intervention

KW - psychological insulin resistance

KW - randomised control trial

KW - type 2 diabetes

U2 - 10.1111/dme.14759

DO - 10.1111/dme.14759

M3 - Journal article

C2 - 34865232

VL - 39

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

M1 - e14759

ER -

ID: 291543815